Myomo Inc Revenue Growth Rates (MYO), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Myomo Inc   (NYSEAMER: MYO)
 

MYO's Revenue Growth by Quarter and Year

Myomo Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MYO Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 12.11
1st Quarter March 9.90
FY 22.01

MYOs Annual Revenue
Myomo Inc 's Revenue in the fiscal year 2025 $ 40.89 millions
Myomo Inc 's Revenue in the fiscal year 2024 $ 32.19 millions
Myomo Inc 's Revenue in the fiscal year 2023 $ 19.18 millions
Myomo Inc 's Revenue in the fiscal year 2022 $ 15.56 millions
Myomo Inc 's Revenue in the fiscal year 2021 $ 13.86 millions




MYO Revenue second quarter 2026 Y/Y Growth Comment
Myomo Inc reported Revenue improvement of 33.85% year on year in the second quarter 2026, to $ 12.11 millions, this is lower than Myomo Inc 's recent average Revenue rise of 57.47%.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 115 other companies have achieved higher Revenue growth. While Myomo Inc ' s Revenue rise of 33.85% ranks overall at the positon no. 2138 in the second quarter 2026.


MYO Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 1.27 % 111.39 % 47.77 %
3rd Quarter September - 5.47 % 99.33 % 13.1 %
2nd Quarter June 33.85 % 23.47 % 38.83 % 43.48 %
1st Quarter March 3.02 % 191.21 % -4.35 % -10.85 %
FY   - 26.96 % 67.8 % -

Financial Statements
Myomo Inc 's second quarter 2026 Revenue $ 12.11 millions MYO's Income Statement
Myomo Inc 's second quarter 2025 Revenue $ 9.05 millions Quarterly MYO's Income Statement


MYO Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 35.38 % 41.01 % 32.96 %
3rd Quarter September - 4.31 % 22.1 % -14.96 %
2nd Quarter June 22.36 % -5.83 % 122.12 % 53.04 %
1st Quarter March -22.54 % -23.85 % -44.72 % -14.6 %
FY (Year on Year)   - 26.96 % 67.8 % -


Back to MYO Growth rate Comparisons >> Back to MYO Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #116
Healthcare Sector #317
Overall #2138

Revenue Y/Y Growth Statistics
High Average Low
179.35 % 57.47 % -1.65 %
(Jun 30 2021)   (Mar 31 2023)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #116
Healthcare Sector #317
Overall #2138
Revenue Y/Y Growth Statistics
High Average Low
179.35 % 57.47 % -1.65 %
(Jun 30 2021)   (Mar 31 2023)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Myomo Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
150.68 % 18.79 % -44.7 %
(Dec 31 2019)  


MYO's II. Quarter Q/Q Revenue Comment
Myomo Inc achieved in the II. Quarter 2026 above company average sequential Revenue jump of 22.36%, to $ 12.11 millions, from $9.90 millions in the first quarter.
MYO is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 23 other companies have achieved higher Revenue quarter on quarter growth. While Myomo Inc 's Revenue growth quarter on quarter, overall rank is 469.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #24
Healthcare Sector #97
Overall #469
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #24
Healthcare Sector #97
Overall #469
Revenue Q/Q Growth Statistics
High Average Low
150.68 % 18.79 % -44.7 %
(Dec 31 2019)  


MYO's II. Quarter Q/Q Revenue Comment
Myomo Inc achieved in the II. Quarter 2026 above company average sequential Revenue jump of 22.36%, to $ 12.11 millions, from $9.90 millions in the first quarter.
MYO is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 23 other companies have achieved higher Revenue quarter on quarter growth. While Myomo Inc 's Revenue growth quarter on quarter, overall rank is 469.


Myomo Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 44.24 $ 41.18 $ 40.89 $ 40.72 $ 40.22
Y / Y Revenue Growth (TTM) 9.99 % 6.97 % 27.04 % 59.46 % 90.82 %
Year on Year Revenue Growth Overall Ranking # 176 # 118 # 92 # 231 # 338
Seqeuential Revenue Change (TTM) 7.43 % 0.71 % 0.42 % 1.23 % 4.49 %
Seq. Revenue Growth (TTM) Overall Ranking # 2138 # 673 # 315 # 552 # 861


Cumulative Revenue growth Comment
Although Myomo Inc 's Annual Revenue growth year on year were below company's average 57.47% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 9.99% year on year, from 6.97% in Mar 31 2026.

In the Healthcare sector 49 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 118 to 176.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 116
Healthcare Sector # 50
Overall # 176

Revenue TTM Y/Y Growth Statistics
High Average Low
179.35 %
 57.47 %
-1.65 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 116
Sector # 317
S&P 500 # 2138
Cumulative Revenue growth Comment
Although Myomo Inc 's Annual Revenue growth year on year were below company's average 57.47% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 9.99% year on year, from 6.97% in Mar 31 2026.

In the Healthcare sector 49 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 118 to 176.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 116
Healthcare Sector # 50
Overall # 176

Revenue TTM Y/Y Growth Statistics
High Average Low
179.35 %
57.47 %
-1.65 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 116
Sector # 317
S&P 500 # 2138




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
MYO's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue jump for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Nephros Inc 58.55%$ 58.551 millions
Bioadaptives Inc 54.95%$ 54.955 millions
Zevra Therapeutics Inc 53.25%$ 53.251 millions
Beyond Air Inc 52.94%$ 52.941 millions
Caredx Inc 52.23%$ 52.226 millions
Bioxcel Therapeutics Inc 51.67%$ 51.667 millions
Glaukos Corp50.63%$ 50.628 millions
Heartflow Inc 49.80%$ 49.801 millions
Coya Therapeutics Inc 48.97%$ 48.974 millions
Travere Therapeutics Inc 48.17%$ 48.174 millions
Halozyme Therapeutics Inc 47.67%$ 47.673 millions
Eli Lilly And Company47.67%$ 47.670 millions
Rhythm Pharmaceuticals Inc 46.91%$ 46.911 millions
Axsome Therapeutics Inc 45.54%$ 45.543 millions
Guardant Health Inc 44.33%$ 44.332 millions
Omada Health Inc 43.27%$ 43.273 millions
Mannkind Corporation42.92%$ 42.922 millions
Butterfly Network Inc 42.47%$ 42.466 millions
Beta Bionics Inc 42.26%$ 42.261 millions
Vyne Therapeutics Inc 40.58%$ 40.580 millions
Qhslab Inc 39.98%$ 39.978 millions
Coherus Oncology inc 39.53%$ 39.526 millions
Neurocrine Biosciences Inc 39.49%$ 39.491 millions
Ss Innovations International Inc39.39%$ 39.393 millions
Assembly Biosciences Inc 38.94%$ 38.936 millions
Edap Tms Sa38.85%$ 38.847 millions
Picard Medical Inc 38.62%$ 38.620 millions
Hims and Hers Health Inc 38.41%$ 38.409 millions
Aquestive Therapeutics Inc 38.15%$ 38.149 millions
Mirum Pharmaceuticals Inc 37.92%$ 37.922 millions


About Myomo Inc Revenue Growth Rates (MYO), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Myomo Inc (CIK 1369290).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001193125-26-335149
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Myomo Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.